Literature DB >> 30132920

Ivabradine use as an antiarrhythmic therapy in congenital junctional ectopic tachycardias.

Yakup Ergul1, Erkut Ozturk2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30132920     DOI： 10.1111/pace.13478

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN： 0147-8389            Impact factor:   1.976


× No keyword cloud information.
  2 in total

1.  The Bradycardic Agent Ivabradine Acts as an Atypical Inhibitor of Voltage-Gated Sodium Channels.

Authors:  Benjamin Hackl; Peter Lukacs; Janine Ebner; Krisztina Pesti; Nicholas Haechl; Mátyás C Földi; Elena Lilliu; Klaus Schicker; Helmut Kubista; Anna Stary-Weinzinger; Karlheinz Hilber; Arpad Mike; Hannes Todt; Xaver Koenig
Journal:  Front Pharmacol       Date:  2022-05-02       Impact factor: 5.988

2.  Use of ivabradine in a critically ill pediatric patient with recalcitrant ectopic atrial tachycardia and complex congenital heart disease.

Authors:  Gretchen Hackett; Tracie K Lin; Jason R Imundo
Journal:  HeartRhythm Case Rep       Date:  2022-03-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.